In the US, young and middle-aged women are being diagnosed with lung cancer at higher rates than men
Susan Wojcicki, the late CEO of YouTube, had a message for the world just weeks before she passed away in August: “Lung ...
mskcc.org4d
How MSK Cares for a Young Woman Living With Stage 4 EGFR Lung Cancer
Learn how a young woman diagnosed with stage 4 non-small cell lung cancer had many treatment options because she came to MSK first.
Cure Today13d
FDA Receives Application for Dato-DXd Treatment in EGFR-Mutated NSCLC
For patients with previously treated EGFR-mutated NSCLC, a new BLA has been submitted to the FDA seeking the accelerated ...
The American Journal of Managed Care9d
Research Priorities Evolve With Amivantamab's Broader NSCLC Indications
In September, amivantamab (Rybrevant; Johnson & Johnson) received its fourth treatment indication from the FDA to treat ...
Medindia5d
Colorectal Cancer Treatment: Role of Anti-EGFR Antibodies
Explore the challenges and advancements in anti-EGFR antibody treatment for metastatic colorectal cancer. Discover how ...
AFP4d
Delta-Fly Pharma Inc.: Progress Update of the Phase III Clinical Trial of DFP-14323
We are excited to share our latest development status.
LJMU11h
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients
colorectal (colon) cancer; epidermal growth factor receptor (EGFR); RAS; liquid biopsy; rechallenge; cetuximab; RAS; ...
Alpha Biopharma Received NMPA Approval For Zorifertinib Tablets (Zorifer®), The World's First EGFR-TKI For Lung Cancer With Brain Metastases.
Zorifertinib is the first drug in the world to launch a registration clinical trial specifically for advanced NSCLC with CNS metastases and achieve remarkable results. It is also the only* EGFR ...